Evidence map›Paper›PMID 41145898›Full record

ArticleLa Radiologia medica2026

Early post-operative NI-RADS predicts recurrence and survival in high-risk oral cavity squamous cell carcinoma undergoing adjuvant radiotherapy.

Mariangela Massaccesi, Marco Panfili, Rosalinda Calandrelli, Silvia Longo, Francesco Pastore, Francesco Miccichè, Calogero Casà, Stefano Settimi, Dario Antonio Mele, Nicola Dinapoli and 6 more

Abstract read
In one paragraph

Article in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Mariangela MassaccesiDepartment of Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Marco PanfiliDepartment of Neuroradiology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Rosalinda CalandrelliDepartment of Neuroradiology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Silvia LongoDepartment of Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. silvia.longo@policlinicogemelli.it.
Francesco PastoreDepartment of Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Francesco MiccichèU.O.C. Di Radioterapia Oncologica, Fatebenefratelli Isola Tiberina, Gemelli Isola, 00186, Rome, Italy.
Calogero CasàU.O.C. Di Radioterapia Oncologica, Fatebenefratelli Isola Tiberina, Gemelli Isola, 00186, Rome, Italy.
Stefano SettimiUnit of Otorhinolaryngology, "A. Gemelli" University Hospital Foundation IRCCS, Rome, Italy.
Dario Antonio MeleUnit of Otorhinolaryngology, "A. Gemelli" University Hospital Foundation IRCCS, Rome, Italy.
Nicola DinapoliDepartment of Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Ciro MazzarellaDepartment of Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Simona GaudinoDepartment of Neuroradiology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Luca TagliaferriDepartment of Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Jacopo GalliUnit of Otorhinolaryngology, "A. Gemelli" University Hospital Foundation IRCCS, Rome, Italy.
Maria Antonietta GambacortaDepartment of Radiation Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Giovanni AlmadoriUnit of Otorhinolaryngology, "A. Gemelli" University Hospital Foundation IRCCS, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the prognostic value of the Neck Imaging Reporting and Data Systems (NI-RADS) in early post-operative imaging for predicting recurrence and survival outcomes in high-risk oral cavity squamous cell carcinoma (SCC) patients undergoing post-operative radiotherapy (PORT).

methodsThis retrospective study included 84 patients with high-risk oral cavity SCC who were scheduled for PORT after radical surgery between January 2013 and May 2024. Early imaging with contrast-enhanced CT or MRI was performed within 12 weeks post-surgery and scored using the NI-RADS system. Associations between NI-RADS scores, recurrence, and survival outcomes were analyzed using Kaplan-Meier and Cox proportional hazards models.

resultsAlthough NI-RADS was originally designed for post-treatment surveillance, we applied it to early post-operative imaging as an exploratory risk-stratification tool. NI-RADS scores significantly predicted regional disease-free survival (DFS) and overall survival (OS). Patients with higher NI-RADS T and N scores had poorer outcomes. Multivariable analysis confirmed early NI-RADS T as an independent predictor of OS (p = 0.01). Interobserver agreement for NI-RADS classifications was strong (Weighted Kappa: T = 0.837, N = 0.855). Although higher radiotherapy doses were administered to patients with NI-RADS 2-3 scores, these patients demonstrated worse outcomes, reflecting aggressive disease.

conclusionEarly application of NI-RADS in post-operative imaging provides valuable prognostic insights, enabling risk stratification and tailored management in high-risk oral cavity SCC patients. Streamlining imaging workflows and exploring alternative therapeutic strategies for high-risk groups may further optimize outcomes.

Indexed as

Carcinoma, Squamous CellMouth NeoplasmsNeoplasm Recurrence, LocalAdultAgedAged, 80 and overContrast MediaFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPredictive Value of TestsPrognosisRadiotherapy, AdjuvantRetrospective StudiesContrast MediaNeck imaging reporting and data systemsOral cavity squamous cell carcinomaPost-operative radiotherapyRecurrenceSurvival

Identifiers

PMID41145898
PMCPMC12872724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.